Pacemaker lead-associated thrombus in JAK2-positive patient

被引：1
|
作者：
Peter, Laura Barbara [1 ]
机构：
[1] CHU UCL Namur, Site Godinne, Yvoir, Belgium
来源：
ACTA CARDIOLOGICA | 2024年 / 79卷 / 01期
关键词：
D O I：
10.1080/00015385.2023.2262856
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant
    Holtan, S. G.
    Hoyer, J. D.
    Buadi, F. K.
    BONE MARROW TRANSPLANTATION, 2011, 46 (04) : 615 - 615
  • [42] Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant
    S G Holtan
    J D Hoyer
    F K Buadi
    Bone Marrow Transplantation, 2011, 46 : 615 - 615
  • [43] TREATMENT OF PACEMAKER-ASSOCIATED RIGHT ATRIAL THROMBUS WITH 2-HOUR RTPA INFUSION
    COOPER, CJ
    DWEIK, R
    GABBAY, S
    AMERICAN HEART JOURNAL, 1993, 126 (01) : 228 - 229
  • [44] Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease
    Fortescue, EB
    Berul, CI
    Cecchin, F
    Walsh, EP
    Triedman, JK
    Alexander, ME
    HEART RHYTHM, 2004, 1 (02) : 150 - 159
  • [45] Complete remission in a patient with JAK2-and IDH2-positive myelofibrosis
    Masarova, Lucia
    Wang, Wei
    Newberry, Kate J.
    Kantarjian, Hagop
    Verstovsek, Srdan
    BLOOD, 2016, 128 (06) : 877 - 880
  • [46] Study of V617F JAK2-positive and JAK2-negative patients within 18 families with myeloproliferative disorders (MPD): Disease characteristics and evolution, EPOR and MPL analysis.
    Bellanne-Chantelot, Christine
    Labopin, Myriam
    Bellanger, Florence
    Chaumarel, Isabelle
    Isnard, Franpoise
    Casadevall, Nicole
    Vainchenker, William
    Thomas, Gilles
    Najman, Albert
    BLOOD, 2006, 108 (11) : 202A - 202A
  • [47] Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis
    Link, Cornelia S.
    Platzbecker, Uwe
    Kroschinsky, Frank
    Pannach, Sven
    Thiede, Christian
    Platzek, Ivan
    Ehninger, Gerhard
    Schuler, Markus K.
    CASE REPORTS IN ONCOLOGY, 2013, 6 (02): : 311 - 315
  • [48] Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
    Riley, Caroline H.
    Hansen, Morten
    Brimnes, Marie K.
    Hasselbalch, Hans C.
    Bjerrum, Ole W.
    Straten, Per Thor
    Svane, Inge Marie
    Jensen, Morten Krogh
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 227 - 234
  • [49] Towards a molecular mechanism for lead-associated anemia:: metal-binding studies on Zn2+-dependent aminolevulinate dehydratase
    Godwin, HA
    Ghering, AB
    Wang, J
    Padia, S
    JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 74 (1-4) : 141 - 141
  • [50] Thrombocytosis and Megakaryocytic Proliferation Are the Early Presentations in Patients With Jak2-Positive Myeloproliferative Neoplasm at age 50 or Younger With Clinical Follow-up and Cytogenetic Correlation
    Xie, Ming
    Ma, Hongwei
    Crisan, Domnita
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A086 - A086
12345